Peptide-based vaccines are composed of short, synthetically produced peptides that mimic protein fragments from pathogens. These peptides are selected for their ability to be recognized by the immune system, particularly T cells. Unlike traditional vaccines that use whole pathogens or large protein subunits, peptide-based vaccines focus on specific antigenic determinants, enhancing specificity and reducing the risk of adverse reactions.
